Founded in 2006, Cryoviva is a leading healthcare and life sciences company and a visionary venture of the RJ Group, reflecting the Group’s long-term commitment to advancing regenerative medicine and stem cell science. Over the past decade and a half, Cryoviva has emerged as a pioneering force in the stem cell industry by combining scientific rigor, ethical clinical practices, and a clear global outlook. Cryoviva offers comprehensive solutions across umbilical cord blood and tissue banking, cellular therapies, and next-generation stem cell applications. The company focuses on translating cutting-edge science into meaningful real-world medical outcomes. Headquartered in Gurugram, the company operates a 28,000 sq. ft. state-of-the-art stem cell processing and storage facility built to international standards. Leveraging advanced cryopreservation technologies and globally accredited protocols—including a closed-bag collection system and AABB-aligned practices—Cryoviva has established itself as one of the most trusted names in India’s stem cell banking sector.

It has earned the confidence of over 350,000 families who have entrusted the company with preserving their child’s stem cells for future medical needs. Beyond India, Cryoviva has built a strong international footprint, making it the only Indian cord blood bank with a sustained presence in markets such as Philippines, Thailand, Singapore, Indonesia, the UAE, Nepal, Vietnam, the Gulf region, and East Africa. This global reach reinforces Cryoviva’s mission to make safe, reliable, and life-saving stem cell technologies accessible across geographies.

For details visit: https://cryovivalifesciences.in/